181 related articles for article (PubMed ID: 29242506)
1. MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.
Leivonen SK; Icay K; Jäntti K; Siren I; Liu C; Alkodsi A; Cervera A; Ludvigsen M; Hamilton-Dutoit SJ; d'Amore F; Karjalainen-Lindsberg ML; Delabie J; Holte H; Lehtonen R; Hautaniemi S; Leppä S
Blood Cancer J; 2017 Dec; 7(12):654. PubMed ID: 29242506
[TBL] [Abstract][Full Text] [Related]
2. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA
Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320
[TBL] [Abstract][Full Text] [Related]
4. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of MiRNA in Patients with Diffuse Large B-Cell Lymphoma: a Meta-Analysis.
Zheng Z; Li X; Zhu Y; Gu W; Xie X; Jiang J
Cell Physiol Biochem; 2016; 39(5):1891-1904. PubMed ID: 27771712
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
9. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
[TBL] [Abstract][Full Text] [Related]
10. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
[TBL] [Abstract][Full Text] [Related]
11. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY
Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973
[TBL] [Abstract][Full Text] [Related]
12. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential key genes associated with diffuse large B-cell lymphoma based on microarray gene expression profiling.
Luo X; Shi F; Qiu H; Tong Y; Gao X
Neoplasma; 2017; 64(6):824-833. PubMed ID: 28895406
[TBL] [Abstract][Full Text] [Related]
14. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
Cao QW; Li HY; Yao XX; Wang JF
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
[TBL] [Abstract][Full Text] [Related]
15. miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
Li J; Fu R; Yang L; Tu W
Int J Clin Exp Pathol; 2015; 8(11):15019-24. PubMed ID: 26823838
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198.
Wang R; Shen J; Wang Q; Zhang M
Biomed Pharmacother; 2018 Dec; 108():43-49. PubMed ID: 30216798
[TBL] [Abstract][Full Text] [Related]
17. Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin.
Sun N; Wang CY; Sun YQ; Ruan YJ; Huang YY; Su T; Zhou XH; Huang H; Guo WJ; He MQ; Yao RX; Lin XJ
Biomed Pharmacother; 2018 Oct; 106():267-274. PubMed ID: 29966970
[TBL] [Abstract][Full Text] [Related]
18. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
19. Aberrant ERG expression associates with downregulation of miR-4638-5p and selected genomic alterations in a subset of diffuse large B-cell lymphoma.
Zhang S; Wang L; Cheng L
Mol Carcinog; 2019 Oct; 58(10):1846-1854. PubMed ID: 31237044
[TBL] [Abstract][Full Text] [Related]
20. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
